Melanie Morel-Ferris
Nessuna posizione attualmente
Profilo
Melanie Morel-Ferris worked as a Corporate Controller at Astrodyne Corp.
from 2014 to 2016, an Associate Director-Accounting at ARIAD Pharmaceuticals, Inc. in 2014, and a Senior Director-Finance & Controller at Invivo Therapeutics Holdings Corp.
in 2017.
She obtained an undergraduate degree from Assumption College.
Precedenti posizioni note di Melanie Morel-Ferris
Società | Posizione | Fine |
---|---|---|
INVIVO THERAPEUTICS HOLDINGS CORP. | Direttore Finanziario/CFO | 29/03/2017 |
Astrodyne Corp.
Astrodyne Corp. Electrical ProductsProducer Manufacturing Astrodyne Corp. manufactures switching power supply and converters. The firm’s products include power supplies and EMI filters for industrial, semiconductor manufacturing, medical, consumer appliance, military, and aerospace sectors. The company was founded in 1994 and is headquartered in Mansfield, MA. | Comptroller/Controller/Auditor | 01/05/2016 |
ARIAD PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/07/2014 |
Formazione di Melanie Morel-Ferris
Assumption College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
INVIVO THERAPEUTICS HOLDINGS CORP. | Health Technology |
Aziende private | 2 |
---|---|
Astrodyne Corp.
Astrodyne Corp. Electrical ProductsProducer Manufacturing Astrodyne Corp. manufactures switching power supply and converters. The firm’s products include power supplies and EMI filters for industrial, semiconductor manufacturing, medical, consumer appliance, military, and aerospace sectors. The company was founded in 1994 and is headquartered in Mansfield, MA. | Producer Manufacturing |
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Melanie Morel-Ferris